BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
May 5, 2026
Company
Minerva Neurosciences, Inc. (NERV)
Other upcoming events for NERV
Phase 3 Readout
Phase 3 Topline: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Monotherapy Study to Evaluate
Dec 1, 2028
Phase 3 Readout
Phase 3 Topline: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Monotherapy Study to Evaluate
Dec 1, 2028
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
NERV Overview
PDUFA Dates
Phase 3 Readouts
Earnings Report — NERV Earnings Report | BioSniper